Berdazimer Topical

Berdazimer Topical is a prescription medication indicated for the treatment of molluscum contagiosum in adults and pediatric patients aged 1 year and older.

• Berdazimer Topical is available under the following different brand names: Zelsuvmi.

Common side effects of Berdazimer Topical include:

• pain
• swelling
• burning 
• breakdown of the outer layer of the skin (erosion)
• stinging 
• lightening or darkening of the skin
• redness 
• blisters
• itching 
• irritation
• peeling or flaking 
• infection
• itchy, dry skin rash

Serious side effects of Berdazimer Topical include:

• application site reactions, including allergic skin reactions, 

Rare side effects of Berdazimer Topical include:

• none 

Seek medical care or call 911 at once if you have the following serious side effects:

• Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, coordination loss, unsteady, very stiff muscles, high fever, profuse sweating, or tremors.
• Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights.
• Serious heart symptoms include fast, irregular, or pounding heartbeats; fluttering in the chest; shortness of breath; sudden dizziness, lightheadedness, or passing out.

This is not a complete list of side effects and other serious side effects or health problems that may occur because of the use of this drug. Call your doctor for medical advice about serious side effects or adverse reactions. You may report side effects or health problems to FDA at 1-800-FDA-1088.

Adult and pediatric dosage

Topical gel

• 10.3%

Molluscum contagiosum

Adult and pediatric dosage

• Apply topical gel as an even thin layer once a day to each MC lesion for up to 12 weeks 

Dosage Considerations – Should be Given as Follows: 

• See “Dosages”

If your medical doctor is using this medicine to treat your pain, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, healthcare provider, or pharmacist first.

• Berdazimer Topical has no noted severe interactions with any other drugs
• Berdazimer Topical has no noted serious interactions with any other drugs
• Berdazimer Topical has no noted moderate interactions with any other drugs
• Berdazimer Topical has no noted minor interactions with any other drugs

This information does not contain all possible interactions or adverse effects. Visit the RxList Drug Interaction Checker for any drug interactions. Therefore, before using this product, tell your doctor or pharmacist about all the products you use. Keep a list of all your medications with you and share this information with your doctor and pharmacist. Check with your healthcare professional or doctor for additional medical advice, health questions, or concerns.

Contraindications

• None

Effects of drug abuse

• None

Short-Term Effects

• See “What Are Side Effects Associated with Using Berdazimer Topical?”

Long-Term Effects

• See “What Are Side Effects Associated with Using Berdazimer Topical?”

Cautions

• Application site reactions
  • Application site reactions, including allergic contact dermatitis, reported
  • Suspect allergic contact dermatitis if pain, pruritus, swelling, or erythema occurs at the application site lasting more than 24 hours
  • If allergic contact dermatitis occurs, discontinue gel, and initiate appropriate therapy

Pregnancy and Lactation

• There are no available data regarding use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes
• Lactation
  • Data are unavailable on the presence of berdazimer or its metabolite in either human or animal milk, its effects on breastfed infants or milk production